A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease oleh J Dretzke, R Edlin, J Round, M Connock, C Hulme, J Czeczot, A Fry-Smith, C McCabe, C Meads